Kintara Therapeutics Inc. Gains 36.47%
Tue, Nov 29, 2022 at 07:12 PM
Kintara Therapeutics Inc. (KTRA:NASDAQ) jumped higher at $5.95, representing a gain of 36.5%. On Tue, Nov 29, 2022, KTRA:NASDAQ touched a New 2-Week High of $5.95. The stock appeared on our News Catalysts scanner on Mon, Nov 28, 2022 at 09:04 AM in the 'BIOTECH' category. From Tue, Nov 15, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
About Kintara Therapeutics Inc. (KTRA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- Otonomy, Inc. (OTIC:NASDAQ), 113.82%
- Apollo Endosurgery, Inc. (APEN:NASDAQ), 67.83%
- OncoSec Medical Incorporated (ONCS:NASDAQ), 50.98%
- Kalera Public Limited Company (KAL:NASDAQ), 45.16%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 36.47%
- The Very Good Food Company Inc. (VGFC:NASDAQ), 30.71%
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 27.57%
- Citi Trends, Inc. (CTRN:NASDAQ), 27.46%
- Renalytix AI plc (RNLX:NASDAQ), 24.5%
- Bilibili Inc. (BILI:NASDAQ), 22.32%